Skip to main content
Human Metabolome Technologies, Inc. logo

Human Metabolome Technologies, Inc. — Investor Relations & Filings

Ticker · 6090 ISIN · JP3794530000 T Professional, scientific and technical activities
Filings indexed 73 across all filing types
Latest filing 2025-04-02 Transaction in Own Shar…
Country JP Japan
Listing T 6090

About Human Metabolome Technologies, Inc.

https://humanmetabolome.com/

Human Metabolome Technologies, Inc. is a biotechnology company specializing in metabolomics. As a pioneer and global leader in the field, it leverages proprietary capillary electrophoresis mass spectrometry (CE-MS) based technology for comprehensive metabolome analysis. The company provides a range of analytical services, including global profiling, targeted assays, metabolic flux analysis, and lipidomics. These services support research and development projects, particularly in biomarker discovery and drug development, by delivering high-quality metabolomics data to address complex scientific and medical challenges.

Recent filings

Filing Released Lang Actions
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Transaction in Own Shares Classification · 100% confidence The document is titled "自己株券買付状況報告書" (Report on the Status of Treasury Stock Acquisition) and explicitly references the legal basis as "金融商品取引法第24条の6第1項" (Financial Instruments and Exchange Act Article 24-6, Paragraph 1). This type of filing reports on the company's ongoing share repurchase activities during a specific period (March 1, 2025, to March 31, 2025). This directly corresponds to the definition of reporting on the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). Although it is a regulatory filing, POS is more specific than the general RNS category.
2025-04-02 Japanese
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Transaction in Own Shares
2025-03-28 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains the header "第2四半期報告書" (Second Quarter Report) and explicitly mentions the period covered ("第22期中(自 2024年7月1日 至 2024年12月31日)"). It is a confirmation document ("確認書") related to the filing of this semi-annual report, submitted to the Tohoku Local Finance Bureau Director ("東北財務局長"). A comprehensive report for a period shorter than a year (like a Q2 report) corresponds to an Interim/Quarterly Report (IR). Although this specific document is a confirmation, its core subject matter is the official semi-annual financial report, making 'IR' the most appropriate classification for the underlying document type being referenced and confirmed, rather than a general announcement (RPA/RNS). The length is short, but the content is highly specific to the financial reporting cycle.
2025-02-13 Japanese
半期報告書-第22期(2024/07/01-2025/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Semi-Annual Report' (半期報告書) filed with the Tohoku Local Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow statement for the interim period (July 1, 2024, to December 31, 2024). It is a formal, substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-02-13 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and explicitly states in Section 1 that it is being submitted because resolutions were passed at the company's 21st Annual General Meeting (AGM) held on September 20, 2024, in accordance with financial regulations. Section 2 details the resolutions, which concern the election of directors and audit committee members. This content—reporting the results of shareholder votes on board appointments following a general meeting—directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to an AGM, the primary purpose is reporting the *results* of the vote, not providing the AGM presentation materials (AGM-R).
2024-09-24 Japanese
内部統制報告書-第21期(2023/07/01-2024/06/30)
Governance Information Classification · 100% confidence The document explicitly states its title and basis in the header table: "【提出書類】 内部統制報告書" (Document Submitted: Internal Control Report) and cites the legal basis as "金融商品取引法第24条の4の4第1項" (Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act). The content discusses the framework, scope, criteria, and conclusion regarding the assessment of internal controls over financial reporting ("財務報告に係る内部統制"). This directly corresponds to the definition of an Audit Report / Information (AR), which covers internal or regulatory stress tests and applied accounting principles, although this specific document is an Internal Control Report, which falls under the broader scope of assurance/audit-related documentation not covered by the 10-K. Given the specific options, AR is the closest fit for formal assurance/control reporting outside of the main annual report (10-K). It is not an ER (Earnings Release) as it is a formal control assessment, nor is it a 10-K (Annual Report) as it is a specific control report required under Japanese law.
2024-09-24 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.